Physician profile
Ravi Kumar
NPI 1003859414
$1,278.07
in general payments reported to CMS, 2019-2025
10 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.73 · 2023: $130 · 2024: $831 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729 · Travel and Lodging: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.28 |
| Travel and Lodging | $482.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $482.06 | 2024 | Excelsiusgps Robotic Navigation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.64 | 2021-2023 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $158.74 | 2024 | Breztri |
| Daiichi Sankyo INC. | $122.98 | 2024 | Injectafer |
| Viiv Healthcare Company | $121.35 | 2025 | Apretude |
| Lilly USA, LLC | $94.57 | 2025 | Zepbound |
| Abbvie INC. | $76.53 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.77 | 2024 | |
| Sunovion Pharmaceuticals INC. | $17.03 | 2021 | |
| Organon LLC | $16.40 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.